Found 1 bookmarks
Newest
Metformin reduces the risk of Long COVID or Death over 6 months in an Emulated Target Trial of Primarily Omicron-infected Adults without Diabetes or Prediabetes New-User, Active-Comparator Analysis
Metformin reduces the risk of Long COVID or Death over 6 months in an Emulated Target Trial of Primarily Omicron-infected Adults without Diabetes or Prediabetes New-User, Active-Comparator Analysis

Study in the US during the Omicron wave followed 248 metformin users over 6 months.

Starting metformin within a week of COVID reduced the risk of Long COVID or death by 53%.

Safe and inexpensive with results aligning with earlier data.

#Long Covid#Post-Acute Conditions#Metformin#treatment
·natap.org·
Metformin reduces the risk of Long COVID or Death over 6 months in an Emulated Target Trial of Primarily Omicron-infected Adults without Diabetes or Prediabetes New-User, Active-Comparator Analysis